Search Results

Showing results 3001 - 3010 for cornell weill patient portal

Methods for the Efficient Identification of Ubiquitination Sites by Proteomics | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/methods-efficient-identification-ubiquitination

Novel Target and Inhibitors for prevention and treatment of Tuberculosis | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/novel-target-and-inhibitors-prevention-and

Training a Machine Learning Network in the Presence of Weak or Absent Training Exemplars to Capture Group Intelligence | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/training-machine-learning-network-presence-weak-or

Use of Dabco-Based Compounds as Potassium Channel Blockers and Openers | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/use-dabco-based-compounds-potassium-channel

Improved Cell Culture Media for the Derivation and Maintenance of Murine Embryonic Stem Cells | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/improved-cell-culture-media-derivation-and

Irreversible S1PR2 Antagonists for the Treatment of Inflammation and Fibrosis | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/irreversible-s1pr2-antagonists-treatment

CD36 Inhibition to Reduce Visceral Fat Accumulation and Increase Insulin Sensitivity | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/cd36-inhibition-reduce-visceral-fat-accumulation

A Novel Antiviral Method and Screen for Antiviral Agents | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/novel-antiviral-method-and-screen-antiviral-agents

Method to Isolate Embryonic Stem Cells Directed to Forebrain Interneuron Fate | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/method-isolate-embryonic-stem-cells-directed

Events | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/news-events/events?page=1%2C8&style=upcoming-events

Showing results 3001 - 3010 for cornell weill patient portal